2
Clinical Trials associated with Adipose tissue-derived autologous stem cell therapy(InGeneron, Inc.)Study on safety and efficacy of urinary continence by administration of autologous adipose tissue-derived stem cells for stress urinary incontinence after radical prostatectomy( S-SE-UC-ADSC-SUI-ARP )
Start Date01 Dec 2022 |
Sponsor / Collaborator- |
/ CompletedNot Applicable Safety and Efficacy of Adult Adipose-Derived Stem Cell Injections Into Partial Thickness Rotator Cuff Tears
This is a prospective, randomized, multi-site, safety and efficacy study in subjects with rotator cuff injuries.
Patients will fall into two categories: treatment group (12 subjects) and non-treatment or control group (six subjects). The treatment group will undergo a small liposuction procedure and receive rotator cuff repair treatment with an ultrasound-guided injection of 5cc adipose-derived stem cells (ADSCs) into the point of injury. The control group will receive a 5cc cortisone injection into the point of injury
100 Clinical Results associated with Adipose tissue-derived autologous stem cell therapy(InGeneron, Inc.)
100 Translational Medicine associated with Adipose tissue-derived autologous stem cell therapy(InGeneron, Inc.)
100 Patents (Medical) associated with Adipose tissue-derived autologous stem cell therapy(InGeneron, Inc.)
100 Deals associated with Adipose tissue-derived autologous stem cell therapy(InGeneron, Inc.)